Walleye Capital
ALT icon

Walleye Capital’s Altimmune ALT Stock Holding History

Walleye Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800
Closed -$2.46K – 4698
2026
Q1 		$2.46K Sell
800
-2,700
-77% -$11.5K ﹤0.01% 4228
2025
Q4 		$12.6K Buy
3,500
+3,300
+1,650% +$14.4K ﹤0.01% 4287
2025
Q3 		$754 Sell
200
-8,800
-98% -$34K ﹤0.01% 4383
2025
Q2 		$34.8K Buy
+9,000
New +$48.7K ﹤0.01% 4132
2025
Q1 		– Sell
-8,400
Closed -$60.6K – 4194
2024
Q4 		$60.6K Buy
+8,400
New +$64.2K ﹤0.01% 4306
2024
Q3 		– Sell
-15,300
Closed -$102K – 5221
2024
Q2 		$102K Buy
15,300
+13,900
+993% +$103K ﹤0.01% 4706
2024
Q1 		$14.3K Buy
+1,400
New +$14.2K ﹤0.01% 4998
2022
Q4 		– Sell
-3,200
Closed -$41K – 3146
2022
Q3 		$41K Buy
+3,200
New +$47.2K ﹤0.01% 2629

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's ALT Position: Q2 2026 in Review

Walleye Capital increased its Altimmune (ALT) stake by 424,850% in Q2 2026, buying an estimated $25.4K and bringing the position to 8,499 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Walleye Capital first reported a position in ALT in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.58M in Q2 2022. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Walleye Capital held 8,499 shares of Altimmune worth $25.8K as of Q2 2026.
  • Walleye Capital bought 8,497 Altimmune shares in Q2 2026, an estimated $25.4K.
  • Altimmune made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4343 holding.
  • Walleye Capital first reported a position in Altimmune in Q4 2021 and has held it in 13 quarters since.
  • Walleye Capital's Altimmune position peaked at $1.58M in Q2 2022.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.